In this cohort study of LCS and IPN program patients, approximately 4% were diagnosed with lung cancer over less than half the duration of the NLST cohort, suggesting a greater population-level LCDR through these screening programs than estimated by clinical trial data.
Liao et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: